Literature DB >> 10519913

Molecular characterization of the ligand-receptor interaction of neuropeptide Y.

N Ingenhoven1, A G Beck-Sickinger.   

Abstract

Neuropeptide Y (NPY) consists of 36 amino acids and is one of the most abundant peptides in the peripheral and central nervous system. Several subtypes of NPY receptors have been described (Y1- y6) using segments and analogues of NPY. The Y1-, Y2- and the Y5-receptor, which have been cloned, belong to the G-protein coupled hormone receptor family and will be specially addressed, because they are the endogenous binding sites of neuropeptide Y in human. In contrast, Y4-receptors recognize endogenous PP, Y3 receptors are discussed controversially and the y6-receptor is truncated in human. In this review, we summarize the data of neuropeptide Y with respect to ligand binding, selectivity, receptor structures and ligand-receptor complexes by using ligand analogues, site directed mutagenesis and photoaffinity labeling.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10519913

Source DB:  PubMed          Journal:  Curr Med Chem        ISSN: 0929-8673            Impact factor:   4.530


  6 in total

1.  The neuropeptide Y Y5 receptor mediates the blockade of "photic-like" NMDA-induced phase shifts in the golden hamster.

Authors:  P C Yannielli; M E Harrington
Journal:  J Neurosci       Date:  2001-07-15       Impact factor: 6.167

2.  Neuropeptide-Y alters VTA dopamine neuron activity through both pre- and postsynaptic mechanisms.

Authors:  Katherine Stuhrman West; Aaron G Roseberry
Journal:  J Neurophysiol       Date:  2017-05-03       Impact factor: 2.714

3.  Receptors for NPY and PACAP differ in expression and activity during adipogenesis in the murine 3T3-L1 fibroblast cell line.

Authors:  Martin T Gericke; Joanna Kosacka; Daniela Koch; Marcin Nowicki; Thomas Schröder; Albert M Ricken; Karen Nieber; Katharina Spanel-Borowski
Journal:  Br J Pharmacol       Date:  2009-04-27       Impact factor: 8.739

4.  The interaction of neuropeptide Y with negatively charged and zwitterionic phospholipid membranes.

Authors:  Lars Thomas; Holger A Scheidt; Andrea Bettio; Annette G Beck-Sickinger; Daniel Huster; Olaf Zschörnig
Journal:  Eur Biophys J       Date:  2009-03-25       Impact factor: 1.733

5.  Neuropeptide Y induces ischemic angiogenesis and restores function of ischemic skeletal muscles.

Authors:  Edward W Lee; Mieczyslaw Michalkiewicz; Joanna Kitlinska; Ivana Kalezic; Hanna Switalska; Peter Yoo; Amarin Sangkharat; Hong Ji; Lijun Li; Teresa Michalkiewicz; Milos Ljubisavljevic; Hakan Johansson; Derrick S Grant; Zofia Zukowska
Journal:  J Clin Invest       Date:  2003-06       Impact factor: 14.808

6.  Physiogenomic comparison of human fat loss in response to diets restrictive of carbohydrate or fat.

Authors:  Richard L Seip; Jeff S Volek; Andreas Windemuth; Mohan Kocherla; Maria Luz Fernandez; William J Kraemer; Gualberto Ruaño
Journal:  Nutr Metab (Lond)       Date:  2008-02-06       Impact factor: 4.169

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.